The United States market has shown robust performance, climbing 1.8% over the last week and 28% in the past year, with earnings forecasted to grow by 17% annually. In this thriving environment, identifying high growth tech stocks involves focusing on companies that demonstrate strong innovation and adaptability to capitalize on these positive trends.
Top 10 High Growth Tech Companies In The United States
| Name | Revenue Growth | Earnings Growth | Growth Rating |
|---|---|---|---|
| AppLovin | 21.01% | 21.70% | ★★★★★★ |
| Sandisk | 39.91% | 40.96% | ★★★★★★ |
| Krystal Biotech | 29.09% | 36.48% | ★★★★★★ |
| 21.88% | 25.36% | ★★★★★★ | |
| Palantir Technologies | 30.22% | 31.80% | ★★★★★★ |
| Fabrinet | 21.38% | 23.34% | ★★★★★★ |
| Marker Therapeutics | 64.28% | 69.04% | ★★★★★★ |
| Tenaya Therapeutics | 59.68% | 60.87% | ★★★★★☆ |
| Gorilla Technology Group | 60.70% | 164.86% | ★★★★★☆ |
| KVH Industries | 28.67% | 146.09% | ★★★★★☆ |
Click here to see the full list of 68 stocks from our US High Growth Tech and AI Stocks screener.
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Natera, Inc. is a diagnostics company that focuses on developing and commercializing molecular testing services globally, with a market cap of approximately $29.09 billion.
Operations: The company generates revenue primarily through the development and commercialization of molecular testing services, amounting to $2.50 billion.
Natera’s strategic focus on enhancing cancer treatment precision through its SIGNAL-ER 101 trial and Panorama NIPT improvements highlights its innovative approach in the high-growth tech sector. The company’s R&D efforts, instrumental in these advancements, have significantly shaped its product offerings. For instance, the recent enhancements to Panorama NIPT are supported by a robust clinical validation study, showcasing Natera’s commitment to addressing complex medical needs through technological innovation. These developments not only reinforce Natera’s position in prenatal and cancer diagnostics but also demonstrate potential for long-term impact on patient management and healthcare costs.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Zscaler, Inc. is a global cloud security company with a market capitalization of approximately $20.44 billion.
Operations: The company generates revenue primarily through the sales of subscription services to its cloud platform and related support services, amounting to $3.17 billion.
Zscaler’s strategic alliances and innovative initiatives, such as the recent Project AI-Guardian and healthcare security blueprints with IGEL, underscore its commitment to advancing cloud security. The company has raised its fiscal 2026 revenue guidance to between $3.33 billion and $3.34 billion, reflecting a robust growth trajectory of approximately 24.7%. Despite reporting a net loss in the third quarter, Zscaler’s significant R&D investment is pivotal in driving these technological advancements and partnerships that cater to complex cybersecurity needs across various sectors. This approach not only enhances Zscaler’s product offerings but also positions it strongly within the high-demand tech landscape of secure digital transformations.
Simply Wall St Growth Rating: ★★★★★☆
Overview: HubSpot, Inc. offers a cloud-based customer relationship management platform for businesses across the Americas, Europe, and the Asia Pacific with a market capitalization of approximately $10.28 billion.
Operations: The company generates revenue primarily from its Internet Software & Services segment, amounting to $3.30 billion.
HubSpot’s recent transition from a net loss to posting a net income of $32.55 million in Q1 2026 underscores its robust recovery and strategic repositioning within the tech landscape. The company’s revenue surged by 23% to $881 million, outpacing previous figures, with projections for continued growth at an annual rate of 13.3%. This performance is bolstered by innovative product launches like HubSpot AEO, which optimizes business visibility across AI platforms, enhancing user engagement and operational efficiency. Additionally, the repurchase of shares worth nearly $400 million reflects confidence in its financial health and commitment to shareholder value.
Make It Happen
- Embark on your investment journey to our 68 US High Growth Tech and AI Stocks selection here.
- Shareholder in one or more of these companies? Ensure you’re never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
- Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.
Ready To Venture Into Other Investment Styles?
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we’re here to simplify it.
Discover if Natera might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Leave a comment